Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6810394 | 7449111 | I | 6810394-5 | 20100615 | 20100616 | 20100630 | EXP | PHHY2010MX39522 | NOVARTIS PHARMACEUTICAL CORPORATION | 73 | YR | F | Y | 20100630 | CN | MEXICO |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6810394 | 1014007720 | PS | DIOVAN HCT | 1 | ORAL | 1 TABLET (160/12.5 MG) PER DAY | 020818 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6810394 | 1014007720 | HYPERTENSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6810394 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6810394 | EYE HAEMORRHAGE |
| 6810394 | INCORRECT DOSE ADMINISTERED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6810394 | 1014007720 | 20100519 |